Honda K - Search Results

1

Gyawali B, Hayashi N, Tsukuura H, Honda K, Shimokata T, Ando Y. Gyawali B, et al. Among authors: honda k. Scand J Gastroenterol. 2015;50(11):1331-8. doi: 10.3109/00365521.2015.1054423. Epub 2015 Jun 10. Scand J Gastroenterol. 2015. PMID: 26061717 Review.

2

Some questions on the randomized controlled trial of communication skills training for oncologists.

Gyawali B, Tsukuura H, Honda K, Shimokata T, Ando Y. Gyawali B, et al. Among authors: honda k. J Clin Oncol. 2015 Jan 10;33(2):222. doi: 10.1200/JCO.2014.58.4532. Epub 2014 Dec 1. J Clin Oncol. 2015. PMID: 25452450 No abstract available.

3

Flaws in the trial design of IFCT-0802.

Gyawali B, Shimokata T, Honda K, Ando Y. Gyawali B, et al. Among authors: honda k. Ann Oncol. 2015 Sep;26(9):2003. doi: 10.1093/annonc/mdv273. Epub 2015 Jun 25. Ann Oncol. 2015. PMID: 26113649 Free article. No abstract available.

4

Prophylactic Use of Antiemetics for Prevention of Opioid-Induced Nausea and Vomiting: A Questionnaire Survey among Japanese Physicians.

Tsukuura H, Ando Y, Gyawali B, Matsumoto M, Sugishita M, Honda K, Urakawa H, Maeda O, Hasegawa Y. Tsukuura H, et al. Among authors: honda k. J Palliat Med. 2015 Nov;18(11):977-80. doi: 10.1089/jpm.2015.0203. Epub 2015 Aug 20. J Palliat Med. 2015. PMID: 26509390

5

Survival of patients with metastatic breast cancer with or without locoregional therapy.

Honda K, Gyawali B, Ando Y. Honda K, et al. Lancet Oncol. 2015 Dec;16(16):e586. doi: 10.1016/S1470-2045(15)00368-X. Lancet Oncol. 2015. PMID: 26678206 No abstract available.

6

Chemotherapy in locally advanced head and neck squamous cell carcinoma.

Gyawali B, Shimokata T, Honda K, Ando Y. Gyawali B, et al. Among authors: honda k. Cancer Treat Rev. 2016 Mar;44:10-6. doi: 10.1016/j.ctrv.2016.01.002. Epub 2016 Jan 22. Cancer Treat Rev. 2016. PMID: 26924194 Review.

7

Assessment of left ventricular diastolic function during trastuzumab treatment in patients with HER2-positive breast cancer.

Honda K, Takeshita K, Murotani K, Mitsuma A, Hayashi H, Tsunoda N, Kikumori T, Murohara T, Ando Y. Honda K, et al. Breast Cancer. 2017 Mar;24(2):312-318. doi: 10.1007/s12282-016-0705-4. Epub 2016 May 27. Breast Cancer. 2017. PMID: 27234030 Clinical Trial.

8

Should low-income countries invest in breast cancer screening?

Gyawali B, Shimokata T, Honda K, Tsukuura H, Ando Y. Gyawali B, et al. Among authors: honda k. Cancer Causes Control. 2016 Nov;27(11):1341-1345. doi: 10.1007/s10552-016-0812-8. Epub 2016 Sep 28. Cancer Causes Control. 2016. PMID: 27680017

9

Risk of serious adverse events and fatal adverse events with sorafenib in patients with solid cancer: a meta-analysis of phase 3 randomized controlled trials†.

Gyawali B, Shimokata T, Ando M, Honda K, Ando Y. Gyawali B, et al. Among authors: honda k. Ann Oncol. 2017 Feb 1;28(2):246-253. doi: 10.1093/annonc/mdw549. Ann Oncol. 2017. PMID: 27771613 Free article.

10

Muscle wasting associated with the long-term use of mTOR inhibitors.

Gyawali B, Shimokata T, Honda K, Kondoh C, Hayashi N, Yoshino Y, Sassa N, Nakano Y, Gotoh M, Ando Y. Gyawali B, et al. Among authors: honda k. Mol Clin Oncol. 2016 Nov;5(5):641-646. doi: 10.3892/mco.2016.1015. Epub 2016 Sep 13. Mol Clin Oncol. 2016. PMID: 27900103 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,822 results

Search Page